LRRK2 c.1127A>C ;(p.N376T)

Variant ID: 12-40645292-A-C

NM_198578.3(LRRK2):c.1127A>C;(p.N376T)

This variant was identified in 1 publication

View GRCh38 version.




Publications:


Re-purposing clinical kinase inhibitors to enhance chemosensitivity by overriding checkpoints.

Cell Cycle (Georgetown, Tex.)
Beeharry, Neil N; Banina, Eugenia E; Hittle, James J; Skobeleva, Natalia N; Khazak, Vladimir V; Deacon, Sean S; Andrake, Mark M; Egleston, Brian L BL; Peterson, Jeffrey R JR; Astsaturov, Igor I; Yen, Timothy J TJ
Publication Date: 2014

Variant appearance in text: LRRK2: N376T
PubMed Link: 24955955
Variant Present in the following documents:
  • Main text
View BVdb publication page